Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF not applicable to NSRX
Nasus Pharma Ltdhas no history of positive free cash flow, so a DCF model can't project a meaningful intrinsic value.
